You are using an outdated browser. Please upgrade your browser to improve your experience.
HIV Essentials

Please see the most up-to-date Important Safety Information for PREZCOBIX™ (darunavir/cobicistat) at http://rxin

Please see the most up-to-date Important Safety Information for PREZCOBIX™ (darunavir/cobicistat) at http://rxin

HIV Essentials

by Janssen Products, LP.
HIV Essentials
HIV Essentials

What is it about?

Please see the most up-to-date Important Safety Information for PREZCOBIX™ (darunavir/cobicistat) at http://rxin.fo/PRCOisi and Prescribing Information at

HIV Essentials

App Details

Version
2.1.0
Rating
NA
Size
1Mb
Genre
Medical Health & Fitness
Last updated
February 28, 2018
Release date
September 10, 2014
More info

App Store Description

Please see the most up-to-date Important Safety Information for PREZCOBIX™ (darunavir/cobicistat) at http://rxin.fo/PRCOisi and Prescribing Information at
http://rxin.fo/PRCOpi.

Please see the most up-to-date Important Safety Information for PREZISTA® (darunavir) at http://rxin.fo/przISI and Prescribing Information at http://rxin.fo/PRZpi.

Please see the most up-to-date Important Safety Information for INTELENCE® (etravirine) at http://rxin.fo/itlISI and Prescribing Information at http://rxin.fo/itlPI.

Please see the most up-to-date Important Safety Information for EDURANT® (rilpivirine) at http://rxin.fo/EDTisi and Prescribing Information at http://rxin.fo/EDT_pi.


FOR HEALTHCARE PROVIDERS ONLY. The Janssen Therapeutics HIV Essentials App is designed to provide healthcare providers with educational information on HIV and the latest prescribing and clinical information for PREZCOBIX™ (darunavir/cobicistat), PREZISTA® (darunavir), INTELENCE® (etravirine), and EDURANT® (rilpivirine).

Application features:
• HIV Basics: This series of patient-friendly interactive screens presents a comprehensive overview of HIV. Topics include disease overview, HIV life cycle, treatment goals, and medications (iPad only)
• Interactive questionnaires: For patients new or currently on treatment, these questions can allow you to customize patient responses and create personal treatment plans (iPad only)
• Medicines: Share patient-friendly information on medicines available from Janssen Therapeutics (iPad only)
• Resources: Discover tools, apps, and links to share with your patients. These resources can help you and your patients learn more about HIV, service organizations, medicines, and disease management
• Provider Product Information: Product information on PREZCOBIX™, PREZISTA®, INTELENCE®, and EDURANT®
• HIV News Feed: Access professional HIV information, articles, and news in a single location
• Speaker Events Feed: View notifications for upcoming Janssen Therapeutics web-based speaker events
• Access to full PREZCOBIX™, PREZISTA®, INTELENCE®, and EDURANT® Prescribing Information

Please report all product complaints, including side effects and/or adverse events, to the Janssen Scientific Affairs, LLC, Medical Information Center at 1-800-JANSSEN (1-800-526-7736).

This app is not a medical device. The app and the information generated from it should not be used as a basis for any diagnosis, monitoring, management, or treatment. The app is intended for use as an educational tool.

Developed by Janssen Therapeutics, Division of Janssen Products, LP. Data rates from your carrier may apply. Janssen Therapeutics does not charge for the use of this application.

© Janssen Therapeutics, Division of Janssen Products, LP 2015. All Rights Reserved. This application is published by Janssen Therapeutics, which is solely responsible for its contents. Please read our Privacy Policy at http://www.janssentherapeutics.com/privacy-policy and Terms of Use at http://jt.com/legal-notice.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.